Who is affected by this change?

This affects Independence Blue Cross Oncology, Hematology providers on Commercial plans.

When does this change take effect?

This change is effective Oct 29, 2025.

Back to dashboard

CommercialCoverageMedium impact

08.00.67o, Cetuximab (Erbitux®)

Independence Blue Cross·Oncology, Hematology·Pharmacy

Effective date

Oct 29, 2025

We identified it

Jun 19, 2026

Days to comply

—

Summary

The Cetuximab (Erbitux®) pharmacy policy has been reissued with an effective date of October 29, 2025. This appears to be a policy update or renewal for commercial insurance plans, though specific changes are not detailed in the summary provided.

Action Required

Action needed

By October 29, 2025: Billing team should review the full updated Cetuximab (Erbitux®) policy at the provided URL to identify specific changes to coverage, prior authorization requirements, or billing procedures. Update any relevant protocols for oncology patients receiving this medication.

Related policy hubs

Independence Blue Cross policies Oncology Hematology